Dr. Patrick Soon-Shiong

Latest Headlines

Latest Headlines

Soon-Shiong's NantWorks deepens its immuno-oncology ties with Sorrento

Billionaire biotech entrepreneur Patrick Soon-Shiong is expanding his company's relationship with Sorrento Therapeutics, promising $110 million in cash and equity in exchange for the rights to some cancer-fighting immunotherapies.

Ex-employees say Soon-Shiong's Big Data venture is a fraud

NantHealth, an arm of billionaire physician and biotech entrepreneur Patrick Soon-Shiong's empire, promises to improve cancer diagnostics through a marriage of genomics and high-speed computing. But behind its sleek marketing campaign and Soon-Shiong's bravura, the company is misleading customers and putting patients at risk, according to a lawsuit filed by two former employees.

Soon-Shiong's new biotech pairs up with Amgen on a cancer immunotherapy

Billionaire physician and biotech entrepreneur Patrick Soon-Shiong has launched a company devoted to immuno-oncology, licensing a treatment from Amgen to get rolling in the field.

Billionaire Soon-Shiong dives into immuno-oncology with $20M Sorrento venture

Patrick Soon-Shiong, billionaire physician and biotech entrepreneur, wants in on the hottest field in oncology, forming a joint venture with Sorrento Therapeutics to develop therapies that harness the body's immune system to fight cancer.

Billionaire doc teams with Oxford Uni to build 'NASA of biomedicine'

Dr. Patrick Soon-Shiong has teamed up with the University of Oxford and others to further the United Kingdom's plan to build the "NASA of biomedicine." Some of the £141 million ($227 million) investment is earmarked for establishing computing infrastructure to support the U.K.'s genomics project.

Soon-Shiong: Investors should be patient with biotech

In science, there's a 10-year horizon for major innovations to come to fruition, biotech billionaire Patrick Soon-Shiong said, and while that timeline may not jibe with the expectations of many investors, success in the field demands patience.

Celgene bets $25M on Soon-Shiong's personalized medicine play

Billionaire Patrick Soon-Shiong is working to marry Big Data and cancer treatment, and his old friends at Celgene have again stepped in to help out, investing $25 million in NantHealth, a cloud-based oncology brain trust.

Billionaire Soon-Shiong ties a $75M knot with Celgene, vows R&D revolution

Biotech billionaire Patrick Soon-Shiong is back to doing cancer drug deals. And he's working with some very familiar partners at Celgene to build up a new platform for nanoparticle albumin-bound drugs--building on the same tumor-targeting tech used for Abraxane.

Fierce's 10 top biotech billionaires

They are already rich, so why spotlight billionaires like Microsoft Chairman Bill Gates and Teva Chairman Dr. Phillip Frost? Well, the mega-wealthy have made an impact all over the biopharma world,...

Biotech billionaire Soon-Shiong unveils 'convergence' cancer drug startup

The biotech field is covered with startup efforts with cancer drugs, but when Dr. Patrick Soon-Shiong announces one the business world stops and listens.